Cellular origin (s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities

N Chiorazzi, M Ferrarini - Blood, The Journal of the American …, 2011 - ashpublications.org
Several cell types have been suggested as giving rise to chronic lymphocytic leukemia
(CLL), and these suggestions have reflected the sophistication of technology available at the …

Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go

A Puiggros, G Blanco, B Espinet - BioMed research …, 2014 - Wiley Online Library
Chromosomal abnormalities in chronic lymphocytic leukemia (CLL) are detected in up to
80% of patients. Among them, deletions of 11q, 13q, 17p, and trisomy 12 have a known …

Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

E Chigrinova, A Rinaldi, I Kwee, D Rossi… - Blood, The Journal …, 2013 - ashpublications.org
Richter syndrome (RS) occurs in up to 15% of patients with chronic lymphocytic leukemia
(CLL). Although RS, usually represented by the histologic transformation to a diffuse large B …

Identification of functional cooperative mutations of SETD2 in human acute leukemia

X Zhu, F He, H Zeng, S Ling, A Chen, Y Wang, X Yan… - Nature …, 2014 - nature.com
Acute leukemia characterized by chromosomal rearrangements requires additional
molecular disruptions to develop into full-blown malignancy,, yet the cooperative …

The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia

P Ouillette, R Collins, S Shakhan, J Li, C Li… - Clinical Cancer …, 2011 - AACR
Purpose: To further our understanding of the biology and prognostic significance of various
chromosomal 13q14 deletions in chronic lymphocytic leukemia (CLL). Experimental Design …

13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia

M Dal Bo, FM Rossi, D Rossi… - Genes …, 2011 - Wiley Online Library
Deletion at 13q14 is detected by fluorescence in situ hybridization (FISH) in about 50% of
chronic lymphocytic leukemia (CLL). Although CLL with 13q deletion as the sole cytogenetic …

[HTML][HTML] Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia

R Gunnarsson, L Mansouri, A Isaksson… - …, 2011 - ncbi.nlm.nih.gov
Background High-resolution genomic microarrays enable simultaneous detection of copy-
number aberrations such as the known recurrent aberrations in chronic lymphocytic …

Chronic lymphocytic leukemia: a clinical and molecular heterogenous disease

AE Rodriguez-Vicente, MG Díaz, JM Hernández-Rivas - Cancer genetics, 2013 - Elsevier
The clinical heterogeneity that characterizes chronic lymphocytic leukemia (CLL), with
survival times ranging from months to decades, reflects its biological diversity. Our …

Prognostic markers and their clinical applicability in chronic lymphocytic leukemia: where do we stand?

R Rosenquist, D Cortese, S Bhoi, L Mansouri… - Leukemia & …, 2013 - Taylor & Francis
Chronic lymphocytic leukemia (CLL) is a clinically and biologically heterogeneous disease
where the majority of patients have an indolent disease course, while others may …

Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

JR Brown, M Hanna, B Tesar, L Werner, N Pochet… - Clinical Cancer …, 2012 - AACR
Purpose: The disease course of chronic lymphocytic leukemia (CLL) varies significantly
within cytogenetic groups. We hypothesized that high-resolution genomic analysis of CLL …